RACCAGNI, ISABELLA
RACCAGNI, ISABELLA
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
2021 Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm
Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling
2020 Gaglio, Daniela; Bonanomi, Marcella; Valtorta, Silvia; Bharat, Rohit; Ripamonti, Marilena; Conte, Federica; Fiscon, Giulia; Righi, Nicole; Napodano, Elisabetta; Papa, Federico; Raccagni, Isabella; J Parker, Seth; Cifola, Ingrid; Camboni, Tania; Paci, Paola; Maria Colangelo, Anna; Vanoni, Marco; M Metallo, Christian; Moresco, ROSA MARIA; Alberghina, Lilia
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
2018 Raccagni, I; Belloli, S; Valtorta, S; Stefano, A; Presotto, L; Pascali, C; Bogni, A; Tortoreto, M; Zaffaroni, N; Daidone, Mg; Russo, G; Bombardieri, E; Moresco, Rm
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.
2018 Ricciardiello, Francesca; Votta, Giuseppina; Palorini, Roberta; Raccagni, Isabella; Brunelli, Laura; Paiotta, Alice; Tinelli, Francesca; D'Orazio, Giuseppe; Valtorta, Silvia; De Gioia, Luca; Pastorelli, Roberta; Maria Moresco, Rosa; La Ferla, Barbara; Chiaradonna, Ferdinando
Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
2017 Valtorta, Silvia; Lo Dico, Alessia; Raccagni, Isabella; Gaglio, Daniela; Belloli, Sara; S Politi, Letterio; Martelli, Cristina; Diceglie, Cecilia; Bonanomi, Marcella; Ercoli, Giulia; Vaira, Valentina; Ottobrini, Luisa; Moresco, ROSA MARIA
Tumour hypoxia: lessons learnt from preclinical imaging
2017 Raccagni I.; Valtorta S.; Moresco R.M.; Belloli S.
Validation of a new combretastatin A-4 (CA-4) analogue in a colon cancer mouse model using PET imaging
2014 Valtorta S; Raccagni I; Orsisi F; Pagliarin R; Coccetti P; Moresco RM
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1? Evaluation by Different Imaging Modalities
2014 Alessia Lo Dico ,,; Silvia Valtorta ,,; C. Martelli ,; Sara Belloli ,,; U. Gianelli ,; D. Tosi ; S. Bosari ,,; A. Degrassi ; M. Russo ; Isabella Raccagni ,,,; Giovanni Lucignani ,,; Rosa Maria Moresco ,,; Luisa Ottobrini ,,
Influence of glycolytic phenotype on anti-angiogenic therapy response in ovarian cancer xenograft models evaluated by PET imaging
2013 S. Valtorta; I. Raccagni; M. Curtarello; G. Di Grigoli; G. Nardo; E. Zulato; S. Todde; C. Monterisi; S. Indraccolo; R.M. Moresco
MONITORING PRECLINICAL MODEL OF BREAST CANCER WITH [18F]FLT AND [18F]FDG-PET
2013 Belloli S; Bogni A; Valtorta S; Tortoreto M; Pascali C; Raccagni I; Zaffaroni N; Crippa F; Daidone MG; Moresco RM ; Bombardieri E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma | 1-gen-2021 | Valtorta, S; Lo Dico, A; Raccagni, I; Martelli, C; Pieri, V; Rainone, P; Todde, S; Zinnhardt, B; De Bernardi, E; Coliva, A; Politi, Ls; Viel, T; Jacobs, Ah; Galli, R; Ottobrini, L; Vaira, V; Moresco, Rm | |
| Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling | 1-gen-2020 | Gaglio, Daniela; Bonanomi, Marcella; Valtorta, Silvia; Bharat, Rohit; Ripamonti, Marilena; Conte, Federica; Fiscon, Giulia; Righi, Nicole; Napodano, Elisabetta; Papa, Federico; Raccagni, Isabella; J Parker, Seth; Cifola, Ingrid; Camboni, Tania; Paci, Paola; Maria Colangelo, Anna; Vanoni, Marco; M Metallo, Christian; Moresco, ROSA MARIA; Alberghina, Lilia | |
| [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer | 1-gen-2018 | Raccagni, I; Belloli, S; Valtorta, S; Stefano, A; Presotto, L; Pascali, C; Bogni, A; Tortoreto, M; Zaffaroni, N; Daidone, Mg; Russo, G; Bombardieri, E; Moresco, Rm | |
| Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. | 1-gen-2018 | Ricciardiello, Francesca; Votta, Giuseppina; Palorini, Roberta; Raccagni, Isabella; Brunelli, Laura; Paiotta, Alice; Tinelli, Francesca; D'Orazio, Giuseppe; Valtorta, Silvia; De Gioia, Luca; Pastorelli, Roberta; Maria Moresco, Rosa; La Ferla, Barbara; Chiaradonna, Ferdinando | |
| Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models | 1-gen-2017 | Valtorta, Silvia; Lo Dico, Alessia; Raccagni, Isabella; Gaglio, Daniela; Belloli, Sara; S Politi, Letterio; Martelli, Cristina; Diceglie, Cecilia; Bonanomi, Marcella; Ercoli, Giulia; Vaira, Valentina; Ottobrini, Luisa; Moresco, ROSA MARIA | |
| Tumour hypoxia: lessons learnt from preclinical imaging | 1-gen-2017 | Raccagni I.; Valtorta S.; Moresco R.M.; Belloli S. | |
| Validation of a new combretastatin A-4 (CA-4) analogue in a colon cancer mouse model using PET imaging | 1-gen-2014 | Valtorta S; Raccagni I; Orsisi F; Pagliarin R; Coccetti P; Moresco RM | |
| Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1? Evaluation by Different Imaging Modalities | 1-gen-2014 | Alessia Lo Dico ,,; Silvia Valtorta ,,; C. Martelli ,; Sara Belloli ,,; U. Gianelli ,; D. Tosi ; S. Bosari ,,; A. Degrassi ; M. Russo ; Isabella Raccagni ,,,; Giovanni Lucignani ,,; Rosa Maria Moresco ,,; Luisa Ottobrini ,, | |
| Influence of glycolytic phenotype on anti-angiogenic therapy response in ovarian cancer xenograft models evaluated by PET imaging | 1-gen-2013 | S. Valtorta; I. Raccagni; M. Curtarello; G. Di Grigoli; G. Nardo; E. Zulato; S. Todde; C. Monterisi; S. Indraccolo; R.M. Moresco | |
| MONITORING PRECLINICAL MODEL OF BREAST CANCER WITH [18F]FLT AND [18F]FDG-PET | 1-gen-2013 | Belloli S; Bogni A; Valtorta S; Tortoreto M; Pascali C; Raccagni I; Zaffaroni N; Crippa F; Daidone MG; Moresco RM ; Bombardieri E |